Evidence map›Paper›PMID 34377450›Full record

ReviewAnnals of medicine and surgery (2012)2021

COVID-19 and mucormycosis superinfection: Exploring the missing pathophysiological links.

Talal Almas, Waqas Nazar, Tarek Khedro, M Ali Kanawati, Alishba Adnan, Mohammad Almuhaileej, Abdulaziz Alshamlan, Abdulaziz Abdulhadi, Kuvira T Manamperi, Saba Sarfraz

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Atypical clinical features of post COVID-19 mucormycosis: A case series.Clinical and experimental dental research · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Talal AlmasRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Waqas NazarCavan General Hospital, County Cavan, Ireland.
Tarek KhedroRCSI University of Medicine and Health Sciences, Dublin, Ireland.
M Ali KanawatiRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Alishba AdnanKarachi Medical and Dental College, Karachi, Pakistan.
Mohammad AlmuhaileejRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Abdulaziz AlshamlanRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Abdulaziz AbdulhadiRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Kuvira T ManamperiRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Saba SarfrazIslamabad Medical and Dental College, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 continues to unearth new facets that portend grave clinical implications. In recent times, there has been mounting fervor regarding coronavirus disease 2019 and mucormycosis superinfection. While the correlation between the two is conspicuous, the underlying pathophysiological mechanisms that render a patient with coronavirus disease 2019 susceptible to mucormycosis, or vice versa, are still elusive.

Indexed as

COVID-19ImmunosupressionMorbidityMortalityMucormycosis

Identifiers

PMID34377450
PMCPMC8342861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.